Copyright
©The Author(s) 2020.
World J Cardiol. Aug 26, 2020; 12(8): 419-426
Published online Aug 26, 2020. doi: 10.4330/wjc.v12.i8.419
Published online Aug 26, 2020. doi: 10.4330/wjc.v12.i8.419
Table 2 Adherence to guideline-directed statin therapy and patient characteristics by group, n (%)
| All patients (n = 268) | IMC only (n = 211) | IMC/CC (n = 57) | P value |
| Statin prescribed | 107 (50.7) | 42 (73) | 0.002 |
| Appropriate intensity statin prescribed | 117 (55.5) | 35 (61.4) | 0.421 |
| Distribution of population | |||
| Age(years), mean | 55.47 (± 10.11, SD) | 62.14 (± 11.08, SD) | < 0.001 |
| ASCVD | 18(8.5) | 20 (35.1) | < 0.001 |
| DM | 64 (30.3) | 27 (47.3) | 0.016 |
| Hypertension | 125(59.2) | 46 (80.70) | 0.003 |
| Smoking history (current and former) | 55 (26.1) | 27 (47.4) | 0.002 |
| Non-white | 62 (29.4) | 26 (45.6) | 0.021 |
| Hispanic, Latino | 127 (60.2) | 24 (42.1) | 0.015 |
| LDL-C (mg/dL), mean | 123.98 (± 34.77, SD) | 110.36 (± 42.47, SD) | 0.013 |
| TC (mg/dL), mean | 204.13 (± 44.96, SD) | 187.67 (± 50.77, SD) | 0.018 |
| HDL-C (mg/dL), mean | 50.4 (± 14.1, SD) | 53.9 (± 18.6, SD) | 0.126 |
- Citation: Cassagnol M, Hai O, Sherali SA, D’Angelo K, Bass D, Zeltser R, Makaryus AN. Impact of cardiologist intervention on guideline-directed use of statin therapy. World J Cardiol 2020; 12(8): 419-426
- URL: https://www.wjgnet.com/1949-8462/full/v12/i8/419.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i8.419